KRN951, a highly potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, has antitumor activities and affects functional vascular properties: Nakamura K, Taguchi E, Miura T, Yamamoto A, Takahashi K, Bichat F, Guilbaud N, Hasegawa K, Kubo K, Fujiwara Y, Suzuki R, Kubo K, Shibuya M, Isae T, Pharmaceutical Development Laboratories and Pharmaceutical Research Laboratories, Kirin Brewery Co., Ltd., Takasaki, Gunma, Japan

Autor: Metzger, Gregory
Zdroj: In Urologic Oncology: Seminars and Original Investigations 2007 25(4):359-360
Databáze: ScienceDirect
Externí odkaz: